B12 (Methylcobalamin)

B12 (Methylcobalamin) (Inj)

Vitamin B12 (cobalamin) is an essential water-soluble vitamin critical for DNA synthesis, red blood cell formation, neurological function, and homocysteine metabolism. Injectable methylcobalamin (the active form of B12) bypasses GI absorption issues and provides direct cellular delivery. It is used in research and clinical contexts for B12 deficiency, neuropathy, fatigue, cognitive support, and as part of lipotropic injection protocols.

Dosing Protocols

STANDARD PROTOCOL (4-week Cycle followed by Maintenance Period)

Weeks 1-4:50 units (5,000mcg) 1x per week

Maintenance (after the first 4 weeks): 25-50 units (2,500-5,000mcg) 1x per month, indefinitely (no set maintenance period)

MAXIMUM PROTOCOL (10-week Cycle followed by Maintenance Period)

Weeks 1-10: 50 units (5,000mcg) 1x per week

Maintenance (after the first 10 weeks): 50 units (5,000mcg) 1-2x per month, indefinitely (no set maintenance period)

Benefits

• Corrects B12 deficiency and associated anemia (megaloblastic)
• Supports myelin sheath synthesis and peripheral nerve health
• Reduces homocysteine levels — cardiovascular risk factor
• Improves energy levels and reduces fatigue
• Supports cognitive function and may reduce dementia risk
• Essential for DNA methylation and synthesis
• Improves mood — supports serotonin and dopamine synthesis
• Supports sleep quality via melatonin regulation
• Neuroprotective — supports axonal regeneration
• Commonly used in lipotropic (fat-burning) injection blends

Mechanism of Action

Methylcobalamin is the neurologically active form of B12. It serves as a cofactor for methionine synthase (converting homocysteine to methionine) and methylmalonyl-CoA mutase (in mitochondrial energy metabolism). In the nervous system, it supports myelin synthesis and axonal repair. Methylcobalamin also donates methyl groups critical for DNA methylation, gene expression regulation, and neurotransmitter synthesis. Injectable delivery achieves serum B12 levels far exceeding oral supplementation, particularly important for individuals with pernicious anemia or GI malabsorption.

Side Effects

• Injection site pain or mild redness
• Rare allergic reactions (to the preservative, not B12 itself)
• Acne flares in susceptible individuals (rare)
• Mild GI upset if high-dose oral forms are used
• Hypokalemia with initial treatment of severe deficiency (rare)

Side Effect Management

Rotate injection sites to minimize local reactions. Use preservative-free formulations if allergic sensitivity is suspected. Monitor potassium levels when initiating treatment for severe deficiency. Generally one of the safest injectable compounds in research use.

Contraindications

• Known cobalt or cobalamin hypersensitivity
• Leber’s disease (hereditary optic atrophy) — B12 may worsen optic atrophy

Research Citations

• Stabler SP. (2013). Vitamin B12 deficiency. New England Journal of Medicine. DOI: 10.1056/NEJMra010479
• Allen LH. (2009). How common is vitamin B-12 deficiency? American Journal of Clinical Nutrition. DOI: 10.1093/ajcn/89.2.707S
• Watanabe T. (2004). Methylcobalamin and neuropathy. Journal of the Neurological Sciences. DOI: 10.1016/j.jns.2004.11.009

---